Category: Infectious Diseases
IGHID Investigators Discuss Projects As New Academic Year Begins
Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious聽Diseases (IGHID) contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations. Their multi-disciplinary findings will be u … Read more
Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis
Martina Kovarova, PhD Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, 黑料网 researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. Read more.
Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women 鈥� Findings from HPTN 084 Study
Dr. Mike Cohen Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021). … Read more
Addressing Racism鈥檚 Role in the US HIV Epidemic: Qualitative Findings from Three 鈥淓nding the HIV Epidemic鈥� Prevention Projects
Lisa Hightow-Weidman, MD, MPH Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three 鈥淓nding the HIV Epidemic鈥� (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article, Kate Muessig, … Read more
Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda
Victoria Shelus studies antimalarial drug use and practice at drug shops in Uganda, building on the work of Dr. Ross Boyce. Victoria Shelus, a PhD candidate working with Dr. Ross Boyce, explores client and vendor health behavior and practice after a study confirmed more than half of all antimalarials administered in Uganda come from drug shops. In the remote villages of Bugoye su … Read more
Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa
Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million R01 grant award to study the changing epidemiology … Read more
Department of Medicine Grants & Funding: August 1 鈥� August 31, 2022
Division of Rheumatology, Allergy and Immunology Amanda Nelson,聽MD, MSCR, RhMSUS,聽received, a 5-Year, $3.4M NIH grant to investigate intestinal permeability in multi-joint osteoarthritis Saira Sheikh,聽MD, and team聽receive $500K NIH U01 鈥淚nnovation Award鈥澛爁rom FDA鈥檚 Office of Minority Health & Health Equity, to advance diversity and representation in lupus. Amanda Nelson, MD, … Read more
Juliano Honored With IDSA Designation
Jonathan J. Juliano, MD, MSPH, has been named Fellow by the Infectious Diseases Society of America (IDSA), the nation鈥檚 leading infectious diseases professional society. Fellowship in IDSA is one of the highest honors in the field of infectious diseases. It recognizes distinguished physicians and scientists from the United States and around the world who have achieved professiona … Read more
-
Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis
Martina Kovarova, PhD In 2020, more than 1.5 million people around the world died of tuberculosis (TB), marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments. To address that problem, scientists with the 黑料网 Department of Medicine, the 黑料网 Institute for Global Health and Infectious Diseas … Read more
Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens
Andreea Waltmann and the late Steve Meshnick. Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for聽intermittent preventive therapy聽of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, de … Read more
CDC renews five-year funding for vector-borne disease threats
Ross Boyce, MD The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes 黑料网鈥檚 Ross Boyce, MD, MSc, a member of the 黑料网 Institute for Global Health & Infectious Diseases and assistant professor in infectious diseases and e … Read more
Department of Medicine Grants & Funding: July 1 鈥� July 31, 2022
Division of Hematology Patrick Ellsworth, MD,聽received a grant for his project titled 鈥淢echanistic Investigation of Factor IX/Ixa Synergy with Emicizumab鈥� from聽Novo Nordisk 鈥淎ccess to Insight鈥� Division of Nephrology and Hypertension Gang Xi, PhD, and聽Prabir Roy-Chaudhury,聽MD, PhD, FRCP(Edin),聽were聽recently awarded a $2.7 million grant聽by the National Institute of Diabetes and Dig … Read more